Clinical trial

Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment

NCT03112343

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-09-26

PhaseNA

Study timeline

Study start (actual)2017-09-26Date precision: day

Registry last updated2019-04-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusunresolved

Insulin Hypoglycemiaunresolved

Insulin-dependent Diabetes Mellitusunresolved

Interventions

Algorithm-based feedback messagesDEVICE

Personal Health RecordDEVICE

Sponsors & collaborators

Samsung Medical Centerlead sponsor

Ministry of Trade, Industry & Energy, Republic of Koreacollaborator

Korea Evaluation Institute of Industrial Technologycollaborator

Daegu Metropolitan City, Koreacollaborator

ICT Clinical Trial Coordination Centercollaborator

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03112343 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.